AAAAAA
Results:
1-7
|
Results: 7
Authors:
Becouarn, Y
Gamelin, E
Coudert, B
Negrier, S
Pierga, JY
Raoul, JL
Provencal, J
Rixe, O
Krisch, C
Germa, C
Bekradda, M
Mignard, D
Mousseau, M
Citation: Y. Becouarn et al., Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients, J CL ONCOL, 19(22), 2001, pp. 4195-4201
Authors:
Monnet, I
Soulie, P
de Cremoux, H
Saltiel-Voisin, S
Bekradda, M
Saltiel, JC
Brain, E
Dupont-Andre, G
Cvitkovic, E
Citation: I. Monnet et al., Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 19(2), 2001, pp. 458-463
Authors:
Misset, JL
Bleiberg, H
Sutherland, W
Bekradda, M
Cvitkovic, E
Citation: Jl. Misset et al., Oxaliplatin clinical activity: a review, CR R ONC H, 35(2), 2000, pp. 75-93
Authors:
Bekradda, M
Cvitkovic, E
Citation: M. Bekradda et E. Cvitkovic, New possibilities in chemotherapy for colorectal cancer, ANN ONCOL, 10, 1999, pp. 105-111
Authors:
Soulie, P
Garrino, C
Bensamaine, MA
Bekradda, M
Brain, E
Di Palma, M
Goupil, A
Misset, JL
Cvitkovic, E
Citation: P. Soulie et al., Antitumoral activity of oxaliplatin/cisplatin-based combination therapy incisplatin-refractory germ cell cancer patients, J CANC RES, 125(12), 1999, pp. 707-711
Authors:
Cvitkovic, E
Bekradda, M
Citation: E. Cvitkovic et M. Bekradda, Oxaliplatin: A new therapeutic option in colorectal cancer, SEMIN ONCOL, 26(6), 1999, pp. 647-662
Authors:
Culine, S
Bekradda, M
Kramar, A
Rey, A
Escudier, B
Droz, JP
Citation: S. Culine et al., Prognostic factors for survival in patients with brain metastases from renal cell carcinoma, CANCER, 83(12), 1998, pp. 2548-2553
Risultati:
1-7
|